Home LiteratureArticle Details
PMID: 18612147 Published · ppublish English Journal Article

Risk factors for the incidence of breast cancer: do they affect survival from the disease?

Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD

Abstract

Risk factors that influence the incidence of breast cancer may also affect survival after diagnosis. Data from 4,560 women with invasive breast cancer who had taken part in the population-based Studies of Epidemiology and Risk Factors in Cancer Heredity (SEARCH) breast cancer study were used to investigate the influence on survival of variables related to pregnancy, menarche and menopause, prior use of exogenous hormones, height, weight, body mass index (BMI), smoking history, and alcohol intake. In univariate analyses, there was no association between prognosis and age at menarche and menopause, menopausal status at diagnosis, smoking history, or prior use of the oral contraceptive pill. Women whose most recent pregnancy was more than 30 years ago had a 35% reduced risk of dying (95% CI, 8% to 54%) compared with women who had a full-term pregnancy in the past 15 years, and the use of hormone replacement therapy for more than 4 years was associated with a similar risk reduction. BMI was associated with a 3% (95% CI, 1% to 4%) increase in mortality per unit increase. Improved prognosis was seen with increasing current alcohol consumption, with a 2% (95% CI, 1% to 3%) reduction in the risk of death per unit of alcohol consumed per week. The apparent benefit of alcohol intake has not been described before, and our data need to be interpreted with some caution. However, our finding that an increase in BMI is associated with a poorer prognosis supports previously published data and suggests that advice on weight loss should be given to all obese patients with breast cancer.

MeSH Terms
Adult Age Distribution Age of Onset Aged Alcohol Drinking Body Mass Index Breast Feeding Breast Neoplasms/epidemiology,pathology,therapy Cause of Death Cohort Studies Contraceptives, Oral, Hormonal Female Hormone Replacement Therapy Humans Incidence Menarche/physiology Menopause/physiology Middle Aged Neoplasm Invasiveness/pathology Neoplasm Staging Parity Pregnancy Probability Prognosis Proportional Hazards Models Registries Risk Factors Survival Analysis
Chemicals
Contraceptives, Oral, Hormonal
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Barnett Gillian C
Oncology Centre, Box 193, Addenbrooke's Hospital, Hills Rd, Cambridge, CB2 2QQ, United Kingdom. gillbarnett@doctors.org.uk
Shah Mitul
Redman Karen
Easton Douglas F
Ponder Bruce A J
Pharoah Paul D P
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
1527-7755
Published
2008-07-10
Pages
3310-6
Language
English
Region
United States
NLM ID
8309333
Subset
IM
Grants
Cancer Research UK · 10118 · United Kingdom
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com